{
  "trial_id": "NCT00977080",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, stage of chronic kidney disease, duration on hemodialysis, prior use of vitamin D receptor activators or cinacalcet, baseline intact parathyroid hormone (iPTH) level, serum total alkaline phosphatase level, calcium level, calcium-phosphorus product (CaxP), presence of parathyroidectomy history, presence of malignancy, presence of liver disease, use of cytochrome P450 inhibitors or inducers, HIV status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "gender"
        ],
        [
          "History of parathyroidectomy",
          "presence of parathyroidectomy history"
        ],
        [
          "History of malignancy",
          "presence of malignancy"
        ],
        [
          "History of liver disease",
          "presence of liver disease"
        ],
        [
          "Use of cytochrome P450 inhibitors or inducers",
          "use of cytochrome P450 inhibitors or inducers"
        ],
        [
          "HIV status",
          "HIV status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "History of type 1 diabetes mellitus",
        "History of type 2 diabetes mellitus",
        "History of angina",
        "History of coronary artery disease",
        "History of left ventricular hypertrophy",
        "History of myocardial infarction"
      ],
      "remaining_candidate_features": [
        "Age",
        "stage of chronic kidney disease",
        "duration on hemodialysis",
        "prior use of vitamin D receptor activators or cinacalcet",
        "baseline intact parathyroid hormone (iPTH) level",
        "serum total alkaline phosphatase level",
        "calcium level",
        "calcium-phosphorus product (CaxP)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Hemodialysis, Baseline iPTH levels, Serum Total Alkaline Phosphatase levels, Serum Calcium levels, Calcium-phosphorus product,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ]
      ],
      "remaining_reference_features": [
        "History of type 1 diabetes mellitus",
        "History of type 2 diabetes mellitus",
        "History of angina",
        "History of coronary artery disease",
        "History of left ventricular hypertrophy",
        "History of myocardial infarction"
      ],
      "remaining_candidate_features": [
        "Age",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of Hemodialysis",
        "Baseline iPTH levels",
        "Serum Total Alkaline Phosphatase levels",
        "Serum Calcium levels",
        "Calcium-phosphorus product"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Hemodialysis vintage, iPTH level, Serum Total Alkaline Phosphatase level, Calcium level, Calcium-phosphorus product, Vitamin D receptor activator use, Cinacalcet use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ]
      ],
      "remaining_reference_features": [
        "History of type 1 diabetes mellitus",
        "History of type 2 diabetes mellitus",
        "History of angina",
        "History of coronary artery disease",
        "History of left ventricular hypertrophy",
        "History of myocardial infarction"
      ],
      "remaining_candidate_features": [
        "Age",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Hemodialysis vintage",
        "iPTH level",
        "Serum Total Alkaline Phosphatase level",
        "Calcium level",
        "Calcium-phosphorus product",
        "Vitamin D receptor activator use",
        "Cinacalcet use."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of hemodialysis, duration of chronic kidney disease, history of vitamin D receptor activators or cinacalcet use, iPTH level, serum total alkaline phosphatase level, calcium level, calcium-phosphorus product, comorbidities (e.g., diabetes, hypertension), concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "History of type 1 diabetes mellitus",
        "History of type 2 diabetes mellitus",
        "History of angina",
        "History of coronary artery disease",
        "History of left ventricular hypertrophy",
        "History of myocardial infarction"
      ],
      "remaining_candidate_features": [
        "Age",
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "duration of hemodialysis",
        "duration of chronic kidney disease",
        "history of vitamin D receptor activators or cinacalcet use",
        "iPTH level",
        "serum total alkaline phosphatase level",
        "calcium level",
        "calcium-phosphorus product",
        "comorbidities (e.g., diabetes, hypertension)",
        "concomitant medications."
      ]
    }
  }
}